In head-to-head comparisons, Tirzepatide has been shown to achieve superior reductions in both HbA1c and body weight, though it may also have a more complex receptor interaction profile (Heise et al.)
10.1242/bio.2012646 76 KaltsasA.ZikopoulosA.MarkouE.ZachariouA.StavropoulosM.KratirasZ.et al (2024)
Two drugs mixed together, not a unimolecular agonist
One patient told me hed bite it if its sweet, hed throw it away
Court Decision Prevents Compounders from Producing Knockoffs of Novo Nordisks Semaglutide Grand View Research, UK GLP-1 Receptor Agonist Market Harvard University, GLP-1 Diabetes and Weight Loss Drug Side Effects: Ozempic Face and More Diabetes.org, How Many People in the UK Have Diabetes? CDC, National Diabetes Statistics Report WHO, Obesity and Overweight Health.com, Think GLP-1s Guarantee Weight Loss